Claritev Corp. (CTEV)
NYSEHealth CareMedical - Healthcare Information ServicesSnapshot 2026-11-04
$20.22-6.69%
Close 2026-11-05 · 1-day change
NYSEHealth CareMedical - Healthcare Information ServicesSnapshot 2026-11-04
QuarterlyIQ Insights · CTEV
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 994.7 | 965.4 | 930.6 | 961.5 | 1,079.7 | 1,117.6 | 937.8 |
| Operating Expenses & Income | |||||||
| Operating Income | 32.5 | 28.8 | (1,389.9) | 162.0 | (362.7) | 386.1 | (131.8) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 392.0 | 326.4 | 333.2 | 303.4 | 267.5 | 335.6 |
| Interest & Investment Income | 1.1 | 1.6 | 3.1 | 8.2 | 3.5 | 0.0 | 0.3 |
| Net Interest Expenses | — | — | — | 325.0 | 299.9 | 267.4 | 335.4 |
| Asset Writedown | — | — | 1,488.9 | 0.0 | 662.2 | 0.0 | 0.0 |
| EBT, Incl. Unusual Items | (369.6) | (373.1) | (1,770.7) | (107.1) | (560.7) | 135.5 | 135.5 |
| Income Tax Expense | (86.5) | (88.8) | (124.9) | (15.4) | 12.2 | 33.4 | 33.4 |
| Net Income | |||||||
| Minority Interest | — | — | — | 0.0 | — | — | — |
| Net Income | (283.1) | (284.3) | (1,645.8) | (91.7) | (572.9) | 102.1 | (520.6) |
| Per Share | |||||||
| Basic EPS | (16.69) | (17.30) | (101.92) | (5.69) | (0.90) | 0.16 | (1.11) |
| Diluted EPS | (16.69) | (17.30) | (101.92) | (5.69) | (0.90) | 0.16 | (1.11) |
| Revenue per Share | 58.63 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 17.0 | 16.4 | 16.1 | 16.1 | 638.9 | 651.0 | 470.8 |
| Diluted Weighted Avg Shares | 17.0 | 16.4 | 16.1 | 16.1 | 638.9 | 651.5 | 470.8 |
| Supplemental | |||||||
| EBIT | 32.5 | 28.8 | (1,389.9) | 162.0 | (362.7) | 386.1 | (131.8) |
| Effective Tax Rate | 23.4% | — | — | 14.3% | -2.2% | 24.6% | 24.6% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.